As winter begins, ECDC is issuing advice to policymakers and public health authorities to protect infants from RSV with immunisation and other preventive measures.
This evidence brief summarises the progress towards UN Sustainable Development Goal 3.3 to ‘end the epidemic of AIDS’ in the EU/EEA. It is largely based on data collected by ECDC through an online reporting tool disseminated to the 30 EU/EEA countries between February and April 2025, followed by data validation during April−June, to monitor implementation of the 2004 Dublin Declaration.
Pre-exposure prophylaxis (PrEP) with antiretroviral medications is a highly effective tool in preventing new HIV infections when taken as prescribed. It is an important element of the ‘combination prevention’ necessary to reach the United Nations (UN) Sustainable Development Goal to end the AIDS epidemic by 2030.
People living with HIV who achieve and maintain viral suppression can lead long, healthy lives and cannot transmit the virus to others. This crucial outcome is contingent upon timely diagnosis, access to treatment, and consistent support.
Join the ECDC Crowd and work on improving and transforming health science one task at a time with your insights on study design, statistical analysis, data collection and interpretation
About ECDC
ECDC collects, analyses and shares data on more than 50 infectious disease topics. ECDC experts assess risks to Europe and provide guidance to help countries prevent and respond to outbreaks and public health threats.
